BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34851477)

  • 1. Gene expression and oxidative stress markers profile associated with toxic metals in patients with renal cell carcinoma.
    Tarabay HH; Abol-Enein H; Awadalla A; Mortada WI; Abdel-Aziz AF
    Mol Biol Rep; 2022 Feb; 49(2):1161-1169. PubMed ID: 34851477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
    Ahmed EA; Youssif ME
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
    Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
    Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.
    Stec R; Grala B; Maczewski M; Bodnar L; Szczylik C
    J Exp Clin Cancer Res; 2009 Oct; 28(1):134. PubMed ID: 19811659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative evaluation of toxic metals and trace elements in the tissues of renal cell carcinoma compared with the adjacent non-cancerous and control kidney tissues.
    Abdel-Gawad M; Elsobky E; Abdel-Hameed M; Abdel-Rahim M; Harraz A; Shokeir AA; Ali-El-Dein B
    Environ Sci Pollut Res Int; 2020 Aug; 27(24):30460-30467. PubMed ID: 32468374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
    Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T
    Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
    Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
    Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
    Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of heavy metals and trace elements in renal cell carcinoma: A case-controlled study.
    Panaiyadiyan S; Quadri JA; Nayak B; Pandit S; Singh P; Seth A; Shariff A
    Urol Oncol; 2022 Mar; 40(3):111.e11-111.e18. PubMed ID: 34961684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.